TQC2731 injection

DRUG5 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Conditions

AsthmaChronic Obstructive Pulmonary DiseaseChronic Rhinosinusitis With Nasal Polyps (CRSwNP)Chronic SinusitisNasal PolypsSevere Asthma

Phase 2

Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.

CompletedNCT05472324

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Severe Asthma

Start: 2022-09-23End: 2025-03-05Updated: 2025-11-20

A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps

CompletedNCT06036927

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chronic Sinusitis, Nasal Polyps

Start: 2023-12-08End: 2025-03-27Updated: 2025-04-16

A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Active, not recruitingNCT06707883

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.Chronic Obstructive Pulmonary Disease

Start: 2024-12-31End: 2027-09-30Updated: 2025-12-12

Phase 3

TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

RecruitingNCT06829784

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.Asthma

Start: 2025-03-21End: 2028-03-01Target: 660Updated: 2026-08-19

Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps

RecruitingNCT07107256

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Start: 2025-09-25End: 2027-09-30Target: 246Updated: 2025-12-16